Breaking barriers: feasibility of a cluster randomised trial evaluating an instrument for identifying and ameliorating adverse drug reactions

Key Points

• The analysis of feasibility demonstrates potential for improving identification of adverse drug reactions through an effective intervention.
• Key evidence indicates that employing innovative instruments, during the cluster randomized trial, could significantly enhance safety outcomes.
• Observational analysis across multiple healthcare settings seeks to determine the practical implications of the intervention for adverse drug reactions.
• This study highlights the importance of developing tools that may lead to better detection and management of adverse reactions in clinical practices.